Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis
Clinical trial NCT05451212 · COMPLETED
Trial details
- NCT number
- NCT05451212
- Sponsor
- Cabaletta Bio
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-23
- Primary completion
- 2025-07-24
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.